Darren Triller, Pharm.D., Senior
Director in IPRO’s Healthcare Quality Improvement group has been invited to serve on the Medical and Scientific Advisory Board for the National Blood Clot
Alliance (NBCA). The NBCA is the nation’s leading patient advocacy organization on the topics of avoidance of thromboembolism and improving the safety and quality of care for such patients. A non-profit, voluntary health organization NBCA is dedicated to advancing the prevention, early diagnosis and successful treatment
of life-threatening blood clots such as deep vein thrombosis, pulmonary embolism and clot-provoked stroke.
NBCA accomplishes its mission through programs that build public awareness, educate patients and healthcare professionals and promote supportive public and private sector policy.
NBCA programs include patient education and professional training on the signs, symptoms and prevention of blood clots and clotting disorders.
NBCA combines the unique perspectives of healthcare providers, individuals afflicted with clotting disorders and community leaders who are passionate about this healthcare crisis. As part of NBCA’s Medical and Scientific Advisory Board (MASAB) Darren joins a prestigious group of nationally recognized experts on thrombosis and thrombophilia.